Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity?

A lot of diseases, including lupus profundus, morphea, lipodystrophy, and Parry-Romberg syndrome, may manifest progressive hemifacial atrophy. These diseases usually progress slowly and rapid progression of atrophy is extremely rare. We report a case of elderly-onset rapid progression of hemifacial...

Full description

Saved in:
Bibliographic Details
Main Authors: Hisashi Nomura, Shohei Egami, Tomoaki Yokoyama, Makoto Sugiura
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Case Reports in Dermatological Medicine
Online Access:http://dx.doi.org/10.1155/2015/478640
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559341085917184
author Hisashi Nomura
Shohei Egami
Tomoaki Yokoyama
Makoto Sugiura
author_facet Hisashi Nomura
Shohei Egami
Tomoaki Yokoyama
Makoto Sugiura
author_sort Hisashi Nomura
collection DOAJ
description A lot of diseases, including lupus profundus, morphea, lipodystrophy, and Parry-Romberg syndrome, may manifest progressive hemifacial atrophy. These diseases usually progress slowly and rapid progression of atrophy is extremely rare. We report a case of elderly-onset rapid progression of hemifacial atrophy only in three weeks. Our case did not meet variable differential diagnoses. We discuss the clinical character of the patient against the past of literature and suppose it may be a new clinical entity.
format Article
id doaj-art-407367f5c15542a58fe5e259f7e4e7ab
institution Kabale University
issn 2090-6463
2090-6471
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Case Reports in Dermatological Medicine
spelling doaj-art-407367f5c15542a58fe5e259f7e4e7ab2025-02-03T01:30:14ZengWileyCase Reports in Dermatological Medicine2090-64632090-64712015-01-01201510.1155/2015/478640478640Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity?Hisashi Nomura0Shohei Egami1Tomoaki Yokoyama2Makoto Sugiura3Department of Dermatology, Shizuoka Municipal Shimizu Hospital, 1231 Miyakami, Shimizu-ku Shizuoka 424-0911, JapanDepartment of Dermatology, Shizuoka Municipal Shimizu Hospital, 1231 Miyakami, Shimizu-ku Shizuoka 424-0911, JapanDepartment of Dermatology, Shizuoka Municipal Shimizu Hospital, 1231 Miyakami, Shimizu-ku Shizuoka 424-0911, JapanDepartment of Dermatology, Shizuoka Municipal Shimizu Hospital, 1231 Miyakami, Shimizu-ku Shizuoka 424-0911, JapanA lot of diseases, including lupus profundus, morphea, lipodystrophy, and Parry-Romberg syndrome, may manifest progressive hemifacial atrophy. These diseases usually progress slowly and rapid progression of atrophy is extremely rare. We report a case of elderly-onset rapid progression of hemifacial atrophy only in three weeks. Our case did not meet variable differential diagnoses. We discuss the clinical character of the patient against the past of literature and suppose it may be a new clinical entity.http://dx.doi.org/10.1155/2015/478640
spellingShingle Hisashi Nomura
Shohei Egami
Tomoaki Yokoyama
Makoto Sugiura
Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity?
Case Reports in Dermatological Medicine
title Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity?
title_full Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity?
title_fullStr Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity?
title_full_unstemmed Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity?
title_short Case of Rapid Progression of Hemiatrophy on the Face: A New Clinical Entity?
title_sort case of rapid progression of hemiatrophy on the face a new clinical entity
url http://dx.doi.org/10.1155/2015/478640
work_keys_str_mv AT hisashinomura caseofrapidprogressionofhemiatrophyonthefaceanewclinicalentity
AT shoheiegami caseofrapidprogressionofhemiatrophyonthefaceanewclinicalentity
AT tomoakiyokoyama caseofrapidprogressionofhemiatrophyonthefaceanewclinicalentity
AT makotosugiura caseofrapidprogressionofhemiatrophyonthefaceanewclinicalentity